why gsk stock down

by Mrs. Maiya Bode Published 3 years ago Updated 2 years ago

Why is the GSK share price down 6%?

Jan 20, 2022 · GSK. UL. NVS. PFE. Shares of GlaxoSmithKline GSK declined 2.4% on Jan 19 after Unilever UL expressed its unwillingness to raise its bid of …

Why is GlaxoSmithKline’s share price falling?

Feb 12, 2020 · GSK share price down after profit warning due to R&D spending GlaxoSmithKline has seen its share price tumble more than 6% in the days following its full-year results, with investors pulling back after the company warned that profits will suffer as it …

How can I get the latest news about GSK?

May 05, 2022 · Check out why GSK Pharma share price is falling today. Get detailed GSK Pharma stock price news and analysis, Dividend, Bonus Issue, Quarterly results information, and more. ... 1 Week: GSK Pharma share price moved down by 3.78%; 1 Month: GSK Pharma share price moved down by 6.19%; 3 Month: GSK Pharma share price moved down by 2.95% ...

Why has GSK split into two companies?

2 days ago · Key Points. GlaxoSmithKline has thus far enjoyed robust sales growth and profits from COVID-19 vaccines and treatments. Much of the company's pipeline now focuses on similar pandemic-related ...

Is GSK stock a good buy now?

Right now, GlaxoSmithKline is sporting a Zacks Rank of #2 (Buy), while Eli Lilly has a Zacks Rank of #3 (Hold). The Zacks Rank favors stocks that have recently seen positive revisions to their earnings estimates, so investors should rest assured that GSK has an improving earnings outlook.Feb 16, 2022

Is GSK stock undervalued?

GlaxoSmithKline reported strong first-quarter results ahead of our estimates, but we don't expect any major fair value estimate change based on the outperformance that was aided by several one-time benefits. We view the stock as undervalued, with the market not fully appreciating Glaxo's growth potential.Apr 27, 2022

Is GSK a buy hold or sell?

There are currently 1 sell rating, 7 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" GlaxoSmithKline stock.

Is GSK a good dividend stock?

Over the last three years, GSK's dividend payout has grown at a 10.38% CAGR. Its four-year average dividend yield is 5.27%, and its current dividend translates to a 4.91% yield.

Will GSK cut dividend?

On aggregate, GSK, as a group, cut the dividend by 31% from £0.80 per share to an expected £0.55 per share for FY 2022. New GSK will pay £0.44 per share in 2022 and the consumer healthcare company is expected to pay £0.11 per share in 2022.Aug 12, 2021

Is GSK a good company to work for?

Glassdoor rating: 3.9

Other GSK Glassdoor reviews spoke highly of training and development and compensation/benefits, and 76% of current employees would recommend GSK as a place to work. An impressive 85% of employees approve of GSK's CEO, Emma Walmsley - the first female CEO to run a top 10 pharmaceutical company.Feb 13, 2019

Is FSK a good stock to buy?

The financial health and growth prospects of FSK, demonstrate its potential to perform inline with the market. It currently has a Growth Score of F. Recent price changes and earnings estimate revisions indicate this would be a good stock for momentum investors with a Momentum Score of B.

What's GSK Pharma share price today and what are GSK Pharma share returns ?

As on 17 Mar, 2022, 03:49 PM IST GSK Pharma share price was down by 0.04% basis the previous closing price of Rs 1,572.2. GSK Pharma share price wa...

What's the market capitalization of GSK Pharma?

Within the Pharmaceuticals sector, GSK Pharma stock has a market cap rank of 15. GSK Pharma has a market cap of Rs 26,622.16 Cr.

Should I buy, sell or hold GSK Pharma?

As per Refinitiv (erstwhile Thomson Reuters), overall mean recommendation by 7 analysts for GSK Pharma stock is to Hold. Recommendation breakup is...

What has been highest price of GSK Pharma share in last 52 weeks?

In last 52 weeks GSK Pharma share had a high price of Rs 1,918.75 and low price of Rs 1,376.00

Who are peers to compare GSK Pharma share price?

Top 5 Peers for GSK Pharma are Pfizer Ltd., Sanofi India Ltd., Abbott India Ltd., Procter & Gamble Health Ltd. and AstraZeneca Pharma India Ltd.

Who are the key owners of GSK Pharma stock?

Promoter,DII and FII owns 75.0, 5.59 and 6.95 shares of GSK Pharma as on 31 Dec 2021 There is no change in promoter holding from 30 Sep 2021 to 31...

What are the key metrics to analyse GSK Pharma Share Price?

Key Metrics for GSK Pharma are: PE Ratio of GSK Pharma is 54.33 Earning per share of GSK Pharma is 28.92 Price/Sales ratio of GSK Pharma is 7.63 Pr...

GSK: technical analysis

Plan your trading week

The latest set of results knocked GSK’s share price back towards the 200-day SMA (£16.62), but once again buyers have stepped in around £16.70, according to chief market analyst at IG, Chris Beauchamp.

Help and support

Get the week’s market-moving news sent directly to your inbox every Sunday. The Week Ahead gives you a full calendar of upcoming economic events, as well as commentary from our expert analysts on the key markets to watch.

Recommendations

Interested in opening an account? Contact 0800 195 3100 or [email protected]

About GSK Pharma

That's all for GSK Pharma recommendations. Check out other stock recos.

GSK Pharma Share Price Update

GlaxoSmithKline Pharmaceuticals Ltd., incorporated in the year 1924, is a Large Cap company (having a market cap of Rs 25,603.18 Crore) operating in Pharmaceuticals sector. GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Service Income and Other Operating Revenue for the year ending 31-Mar-2021.

GlaxoSmithKline Media Sentiment

GlaxoSmithKline Pharmaceuticals Ltd. share price moved down by -1.17 % from its previous close of Rs 1,529.25. GlaxoSmithKline Pharmaceuticals Ltd. stock last traded price is 1,511.35

Media Coverage

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GlaxoSmithKline (LON GSK) News Headlines Today

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

Is GlaxoSmithKline a buy right now?

Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm.

What stocks does MarketBeat like better than GlaxoSmithKline?

13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for GlaxoSmithKline in the last year. There are currently 2 sell ratings, 5 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" GlaxoSmithKline stock.

When is GlaxoSmithKline's next earnings date?

Wall Street analysts have given GlaxoSmithKline a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but GlaxoSmithKline wasn't one of them.

How were GlaxoSmithKline's earnings last quarter?

GlaxoSmithKline is scheduled to release its next quarterly earnings announcement on Wednesday, October 27th 2021.#N#View our earnings forecast for GlaxoSmithKline.

How has GlaxoSmithKline's stock price been impacted by Coronavirus (COVID-19)?

GlaxoSmithKline plc (NYSE:GSK) posted its quarterly earnings data on Wednesday, July, 28th. The pharmaceutical company reported $0.79 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.54 by $0.25.

How often does GlaxoSmithKline pay dividends? What is the dividend yield for GlaxoSmithKline?

GlaxoSmithKline's stock was trading at $39.87 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, GSK stock has decreased by 0.2% and is now trading at $39.78.#N#View which stocks have been most impacted by COVID-19.

Is GlaxoSmithKline a good dividend stock?

GlaxoSmithKline announced a quarterly dividend on Friday, July 30th. Stockholders of record on Friday, August 20th will be paid a dividend of $0.523 per share on Thursday, October 7th. This represents a $2.09 dividend on an annualized basis and a dividend yield of 5.26%.

Signals & Forecast

GlaxoSmithKline pays an annual dividend of $2.09 per share and currently has a dividend yield of 5.16%. GSK has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. GlaxoSmithKline does not yet have a strong track record of dividend growth. The dividend payout ratio of GlaxoSmithKline is 70.13%.

Support, Risk & Stop-loss

There are few to no technical positive signals at the moment. The GlaxoSmithKline PLC stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average.

Is GlaxoSmithKline PLC stock A Buy?

GlaxoSmithKline PLC finds support from accumulated volume at $39.70 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

Where is GSK headquartered?

The GlaxoSmithKline PLC stock holds several negative signals and despite the positive trend, we believe GlaxoSmithKline PLC will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

What does a high stock score mean for GlaxoSmithKline?

GlaxoSmithKline plc is a British pharmaceutical company headquartered in Brentford, London. Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, GSK was the world's sixth largest ... Y!